Six of the identified complement system genes related to AMD diagnostic and therapeutic panel (C2, C3, C9, CFB, CFI, and CFH) belong to the alternative pathway, and one (C1s) belongs to the classical pathway. Here, C2 is linked to age-related macular degeneration.